Skip to main content
Top
Published in: Advances in Therapy 9/2020

Open Access 01-09-2020 | Letter

Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review

Authors: Gerard Bannenberg, Harry B. Rice

Published in: Advances in Therapy | Issue 9/2020

Login to get access

Excerpt

The authors of the review have reproduced figures from two previous publications that show the results of omega-3 dietary supplement quality assessment which has not been carried out in a correct manner.
These reproduced results are misinterpreted with respect to the quality requirements set by industry for dietary supplements and pharmaceutical products, because methods assessing these requirements have not been followed correctly.
The authors failed to cite a replication study reporting conflicting results from one of the cited studies used to substantiate their position.
Recent literature showing good to excellent quality of dietary supplements available to consumers has been omitted.
Literature
1.
go back to reference Hilleman DE, Wiggins BS, Bottorff MB. Critical differences between dietary supplement and prescription omega-3 fatty acids: a narrative review. Adv Ther. 2020 Feb;37(2):656–70. Hilleman DE, Wiggins BS, Bottorff MB. Critical differences between dietary supplement and prescription omega-3 fatty acids: a narrative review. Adv Ther. 2020 Feb;37(2):656–70.
2.
go back to reference Sprague M, Cooper S, Tocher DR, Betancor MB. Encapsulated fish oil products available in the UK meet regulatory guidelines with respect to EPA+DHA contents and oxidative status. Eur J Lipid Sci Technol. 2018;120:1800105.CrossRef Sprague M, Cooper S, Tocher DR, Betancor MB. Encapsulated fish oil products available in the UK meet regulatory guidelines with respect to EPA+DHA contents and oxidative status. Eur J Lipid Sci Technol. 2018;120:1800105.CrossRef
3.
go back to reference Albert BB, Derraik JG, Cameron-Smith D, et al. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep. 2015;5:7928.CrossRef Albert BB, Derraik JG, Cameron-Smith D, et al. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep. 2015;5:7928.CrossRef
4.
go back to reference Bannenberg G, Mallon C, Edwards H, et al. Omega-3 long-chain polyunsaturated fatty acid content and oxidation state of fish oil supplements in New Zealand. Sci Rep. 2017;7:1488.CrossRef Bannenberg G, Mallon C, Edwards H, et al. Omega-3 long-chain polyunsaturated fatty acid content and oxidation state of fish oil supplements in New Zealand. Sci Rep. 2017;7:1488.CrossRef
5.
go back to reference Mason RP, Sherratt SCR. Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits. Biochem Biophys Res Commun. 2017;483(1):425–9.CrossRef Mason RP, Sherratt SCR. Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits. Biochem Biophys Res Commun. 2017;483(1):425–9.CrossRef
Metadata
Title
Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
Authors
Gerard Bannenberg
Harry B. Rice
Publication date
01-09-2020
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 9/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-020-01421-y

Other articles of this Issue 9/2020

Advances in Therapy 9/2020 Go to the issue